FDA Delays Decision on Moderna COVID Vaccine for Younger Teens
By Robert Preidt and Robin Foster HealthDay Reporter MONDAY, Nov. 1, 2021 (HealthDay News) — The U.S. Food and Drug Administration has delayed a decision on whether to approve emergency use of Moderna’s COVID-19 vaccine in 12- to 17-year-olds until at least January, the company announced Sunday. That’s because the agency told the company … Read more